An Offset Patterned Cross-ß Structure in Assemblies of C 3 -Symmetric Peptide Amphiphiles.

Fecha de publicación: Fecha Ahead of Print:

Autores de CIPF

Participantes ajenos a CIPF

  • Melnyk T
  • Nebot VJ
  • Dankers PYW

Grupos de Investigación

Abstract

Developing peptide-based materials with controlled morphology is a critical theme of soft matter research. Herein, we report the formation of a novel, patterned cross-ß structure formed by self-assembled C 3 -symmetric peptide amphiphiles based on diphenylalanine and benzene-1,3,5-tricarboxamide (BTA). The cross-ß motif is an abundant structural element in amyloid fibrils and aggregates of fibril-forming peptides, including diphenylalanine. The incorporation of topological constraints on one edge of the diphenylalanine fragment limits the number of ß-strands in ß-sheets and leads to the creation of an unconventional offset-patterned cross-ß structure consisting of short 3×2 parallel ß-sheets stabilized by phenylalanine zippers. In the reported assembly, two patterned cross-ß structures bind parallel arrays of BTA stacks in a superstructure within a single-molecule-thick nanoribbon. In addition to a threefold network of hydrogen bonds in the BTA stack, each molecule becomes simultaneously bound by hydrogen bonds from three ß-sheets and four phenylalanine zippers. The diffuse layer of alkyl chains with terminal polar groups prevents the nanoribbons from merging and stabilizes cross-ß-structure in water. Our results provide a simple approach to the incorporation of novel patterned cross-ß motifs into supramolecular superstructures and shed light on the general mechanism of ß-sheet formation in C 3 -symmetric peptide amphiphiles.

Datos de la publicación

ISSN/ISSNe:
0947-6539, 1521-3765

CHEMISTRY-A EUROPEAN JOURNAL  WILEY-V C H VERLAG GMBH

Tipo:
Article
Páginas:
-
PubMed:
37967312

Citas Recibidas en Web of Science: 2

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • benzene-1,3,5-tricarboxamide, cross-beta, peptide amphiphiles, self-assembly, supramolecular polymers

Campos de Estudio

Proyectos asociados

Molecular Machines Functioning in Cells

Investigador Principal: MARIA JESUS VICENT DOCON

COMMISSION OF EUROPEAN COMMUNITIES . 2020

Aproximación sinérgica al desarrollo de terapias para tumores metastásicos y desórdenes neurodegenarativos utilizando conjugados polipetídicos versátiles

Investigador Principal: MARIA JESUS VICENT DOCON

MINISTERIO DE CIENCIA, INNOVACION Y UNIVERSIDADES . 2020

Versatile Polypeptide-based Intranasal Drug Delivery Platform(s) to Tackle CNS Disorders. ERC. POLYBRAINT

Investigador Principal: MARIA JESUS VICENT DOCON

COMMISSION OF EUROPEAN COMMUNITIES . 2022

Incorporacion nuevos grupos al CIBER CIBERONC. Punto 3.2 Immunoterapia para tumores sólidos. NOTA: el presupuesto concedido es para le CIBER no para el CIPF

Investigador Principal: MARIA JESUS VICENT DOCON

2022

Nanoplataforma Polipeptídica Multimodal de Precisión para el Tratamiento y Monitorización de Tumores Metastásicos. Colab I-36, I-12, I-63, servicio citómica, uji y gva (Esther Roselló)

Investigador Principal: MARIA JESUS VICENT DOCON

CONSELLERIA DE EDUCACION . 2022

New nanotechnological therapy for Parkinson´s disease: nose to brain delivery of GBA-polymer nanoconjugates

Investigador Principal: MARIA JESUS VICENT DOCON

FUNDACIÓN LA CAIXA . 2022

Modelos de transcriptomica espacial y comunicación celular aplicados a la regeneracion tisular y tratamiento en daño de espina dorsal. Coordina Ana Conesa del CSIC, colaboran MJ.Vicent, V.Moreno, A.Alastrue y A.Armiñan del CIPF

CONSELLERIA DE EDUCACION . 2023

VI RSEQ Chemical Biology Group Meeting- ChemBioVI

Investigador Principal: MARIA JESUS VICENT DOCON

2023

MULTISMART, Multi-component Soft Materials Advanced Research Training Network

Investigador Principal: MARIA JESUS VICENT DOCON

COMMISSION OF EUROPEAN COMMUNITIES . 2023

Providing cutting edge cancer research services across Europe (CanSERV)

Investigador Principal: MARIA JESUS VICENT DOCON

COMMISSION OF EUROPEAN COMMUNITIES . 2022

Sinergias en descubrimiento de fármacos en España. ES-OPENSCREEN_2

Investigador Principal: MARIA JESUS VICENT DOCON

MINISTERIO DE CIENCIA, INNOVACION Y UNIVERSIDADES . 2023

Long-acting injectables

Investigador Principal: MARIA JESUS VICENT DOCON

MINISTERIO DE CIENCIA, INNOVACION Y UNIVERSIDADES . 2023

Compartir